Position in MRNA
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$223,675
-$531,693 QoQ
Shares Held
3,194
-49.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#490
of 777 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Almanack Investment Partners, LLC. holds $2,305,722 across 11 Biotechnology names. MRNA ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HYPD |
Hyperion Defi, Inc.
|
169,013 | $530,700 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
649 | $404,677 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
44,950 | $306,109 | |
| 4 | BHVN |
Biohaven Ltd.
|
17,200 | $255,936 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
3,194 | $223,675 | |
| 6 | RGNX |
REGENXBIO Inc.
|
13,955 | $167,180 | |
| 7 | DTIL |
Precision Biosciences Inc
|
20,428 | $160,564 | |
| 8 | TNYA |
Tenaya Therapeutics, Inc.
|
168,200 | $124,299 |
All Filings in MRNA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,675 | 3,194 | Shares | Sole | 2026-07-30 | |
| 2024-06-30 | $755,368 | 6,361 | Shares | Sole | 2024-10-23 | |
| 2023-03-31 | $227,298 | 1,480 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $921,450 | 5,130 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,723,848 | 14,578 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $409,806 | 2,379 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $417,035 | 1,642 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $295,957 | 769 | Shares | Sole | 2021-11-04 | |
| No filing history on record for this holder in this stock. | ||||||